EUVIMEDOdkrijte EUVIMED
Crossref

Paeonol alleviates intrauterine adhesion by suppressing endometrial stromal cell activation via AKT1, based on network pharmacology

Weilan Liu iD, Wenxin Shi, Jiahua Zheng, Yanfang Du, Yan Jiang, Caifu Zhao, Zhiqiang Zhang, Li Feng, Xianghua Huang

Reproduction, Fertility and Development · 2026-05-11 · 38 (7)

DOI: 10.1071/rd25246 ↗

At a glance

Journal article in Reproduction, Fertility and Development, published online on 2026-05-01. Written by Weilan Liu and 8 co-authors. Institution: Department of Obstetrics and Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, People's Republic of China. Major MEDLINE topics: Acetophenones, Proto-Oncogene Proteins c-akt, Endometrium, Stromal Cells. 34 references.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Context

Intrauterine adhesion (IUA) causes secondary infertility and recurrent miscarriage, yet therapeutic options remain limited. Paeonol is widely used for gynecological diseases, but its precise role in IUA therapy is unclear.

Aims

This study aims to explore the molecular mechanism of paeonol in IUA.

Methods

Network pharmacology identified paeonol’s potential targets and core proteins via a protein–protein interaction network. Bioinformatic pathway enrichment analyses and molecular docking elucidated mechanisms and validated binding. The optimal concentration and treatment time of paeonol were screened using Cell Counting Kit-8 (CCK-8) assays. In a transforming growth factor (TGF)-β-induced activated primary endometrial stromal cell (ESC) model, paeonol’s effects on proliferation and migration were evaluated using CCK-8, wound healing, and Transwell assays. Expression levels of AKT1 and collagen synthesis-related markers were assessed by Western blotting. Protein levels of type I collagen and vimentin were assessed by immunofluorescence staining. In a IUA rat model, the in vivo efficacy of paeonol in alleviating IUA via AKT1 regulation was validated based on pathological, inflammatory, and reproductive parameters. Key results Paeonol targets were significantly enriched in the phosphoinositide 3-kinaseK–AKT pathway. In vitro, paeonol blocked TGF-β-induced activation of primary ESC, reducing cell viability and migration. Mechanistically, paeonol antagonised TGF-β-induced ESC activation by suppressing AKT1, thereby attenuating IUA. In vivo, paeonol alleviated pathological changes of endometrial tissues, reduced fibrosis, and suppressed inflammation in IUA rats.

Conclusion

Paeonol blocks AKT1 activation to suppress inflammation and fibrosis, ultimately slowing IUA progression.

Implications

This study provides a new theoretical basis for paeonol use in IUA therapy.

Subjects

MeSH terms (MEDLINE)

AcetophenonesProto-Oncogene Proteins c-aktEndometriumStromal CellsUterine DiseasesFemaleAnimalsTissue AdhesionsCell MovementRatsCell ProliferationRats, Sprague-DawleySignal TransductionHumansMolecular Docking Simulation

Author keywords

AKT1endometrial stromal cellsfibrosisinflammationintrauterine adhesionnetwork pharmacologypaeonoltransforming growth factor-β

Substances

AcetophenonespaeonolProto-Oncogene Proteins c-aktAkt1 protein, rat

Authors and institutions

  • Department of Obstetrics and Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, People's Republic of China.
  • Hebei Key Laboratory of Regenerative Medicine of Obstetrics and Gynecology, Shijiazhuang, Hebei 050000, People's Republic of China.
  • Physical Examination Center, Hebei General Hospital, Shijiazhuang, Hebei 050051, People's Republic of China.
  • Department of Rehabilitation for Obstetrics and Gynecology, Hebei General Hospital, Shijiazhuang, Hebei 050051, People's Republic of China.
  • Department of Gynecology and Obstetrics, Hebei General Hospital, Shijiazhuang, Hebei 050051, People's Republic of China.
  • Department of Gynecology, Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, Hebei 050000, People's Republic of China.

ORCID profiles: Weilan Liu

Cite

APA

Liu, W., Shi, W., Zheng, J., Du, Y., Jiang, Y., Zhao, C., Zhang, Z., Feng, L., & Huang, X. (2026). Paeonol alleviates intrauterine adhesion by suppressing endometrial stromal cell activation via AKT1, based on network pharmacology. Reproduction, Fertility and Development, 38(7). https://doi.org/10.1071/rd25246

Vancouver

Liu W, Shi W, Zheng J, Du Y, Jiang Y, Zhao C, et al. Paeonol alleviates intrauterine adhesion by suppressing endometrial stromal cell activation via AKT1, based on network pharmacology. Reproduction, Fertility and Development. 2026;38(7). doi:10.1071/rd25246

BibTeX
@article{Liu2026,
  author = {Liu, Weilan and Shi, Wenxin and Zheng, Jiahua and Du, Yanfang and Jiang, Yan and Zhao, Caifu and Zhang, Zhiqiang and Feng, Li and Huang, Xianghua},
  title = {Paeonol alleviates intrauterine adhesion by suppressing endometrial stromal cell activation via AKT1, based on network pharmacology},
  journal = {Reproduction, Fertility and Development},
  year = {2026},
  volume = {38},
  number = {7},
  doi = {10.1071/rd25246}
}
Start for free →